Skip to main content

Task · Step 05

Keep the filing valid

Handle changes, the , adverse reactions, recalls and record keeping.

What this step achieves

Purpose: Keep the filing aligned with the real product and with who is responsible, and meet post-market quality and safety duties.

Changes are filed, annual duties are completed on time, and adverse reaction, recall and sales records can be produced on request. Only then does the filing support continued import and sales.

What you must confirm

  • Whether the product information has changed
  • Whether the was submitted on time
  • Whether the filing is still valid
  • Whether and reporting follow the rules
  • Whether the recall and sales records are complete
  • Whether advertising and e-commerce claims match the filing

How to do it

  1. Decide whether a change is needed

    When the product name, formula, manufacturer, label, pack size or changes, decide first whether a is needed. Key changes should be completed before further import or sale. Provisions on the Administration of Cosmetic Registration and Filing Dossiers

  2. Submit the annual report

    Once the filing is a year old, submit the through the filing platform between 1 January and 31 March. It normally covers production and sales, imports, adverse reaction handling and changes.

  3. Run the adverse reaction process

    Set up collection, recording, assessment, reporting and control. When a possible adverse reaction appears, first record the batch number, how the product was used, the symptoms, any medical treatment and photos. The domestic responsible person then classifies it as general, serious or a cluster event under the Measures for the Administration of Cosmetic Adverse Reaction Monitoring and reports it through the national system. Do not treat complaints as a public-relations issue only.

  4. Manage recalls

    Decide in advance what triggers a recall, who decides, whom to notify, how to control stock and how to record it. When a quality or safety risk appears, assess whether to stop imports, take the product down, notify the channel and recall. If the drug regulator requires risk control or a recall, act within the scope and deadline it sets and keep a full record.

  5. Keep records

    Keep filing submissions, raw testing data, the process, overseas certificates, translations, change records, import and sales records, and adverse reaction and recall records. They should be available at any inspection.

Required documents

  • Change documents

    When triggered

    Prepared when a triggering change occurs.

  • Annual report

    When triggered

    Submitted online in the platform.

  • Adverse reaction and recall records

    Ongoing

    Ongoing post-market duty.

  • Adverse reaction reports

    Ongoing

    Reported as required.

  • Recall and sales records

    Ongoing

    Produced at inspection.

Watch out for

  • Changing the was simplified by NMPA Announcement No. 70 (2026): the former responsible person consent or a court judgment is no longer needed.
  • The window is fixed and short; set a calendar reminder. Build the adverse reaction process before a regulator asks.
  • When you change packaging, upgrade a formula, move production or add a shade, decide whether a change is needed before importing more.

Official basis and links

FAQ

What if the domestic responsible person changes?
File the change in the platform first, then import and sell through the new entity. Under NMPA Announcement No. 70 (2026) the change was simplified: usually you prepare the new authorisation and its notarisation, the list of affected products, and the new undertaking to take over the former one duties. The former responsible person sealed consent or an effective court judgment is no longer required. Check what the platform asks for on the day.
Keep the filing valid · Cosmetics China Entry Guide